New protective compound designed to shield healthy tissue from radiation

Megan Applegate | | Health Imaging | Practice Management

A recently developed radioprotective compound has shown potential to protect healthy tissue from ionizing radiation associated with cancer treatment.

BIO 300 was created by Minneapolis-based Humanetics Corporation and demonstrated promising ability as a therapeutic measure against harm caused by radiation from sources like cancer radiotherapy.

Humanetics said promising preclinical results have led to a clinical trial to evaluate the ability of BIO 300 to lessen the normal tissue side effects from chemotherapy and radiation associated with lung cancer treatment. This trial is scheduled to begin in the second quarter of 2015, according to a company press release.

Megan Applegate

Related Content

Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Bracco's latest move marks a step toward improving sustainability in radiology
New protocol addresses contrast allergies in patients with suspected stroke
Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.